Facts & Figures page states: 10 plants for pharma & healthcare products3 plants for high-quality technologies2 sites for analytical servicesa presence across 10 countriesand export to 70 countries. Regulatory affairs team stated to have a global presence in the U.S.EU and APAC. Named plants include Nuova Ompi (IT-PDIT-LTIT-Cisterna)Ompi of America (FishersIN)Ompi of ChinaOmpi do BrasilBalda Medical (DE)SpamiStevanato Group Denmarkand plants in Monterrey (MX) and Zhangjiagang (CN).
Inspection history · illustrative, historical framing
Inspected by: —. Synthetic demonstration data — not an actual regulatory finding.